News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

WuXi AppTec Merges Formulation/Finishing Services Into API Manufacturing Division



8/1/2017 10:18:06 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
WuXi AppTech will merge its Pharmaceutical Development Services division into STA Pharma, a WuXi listed subsidiary that provides small molecule CRO/CMO services. The transfer adds formulation/finished drug services into STA's API and intermediate manufacturing offerings. PDS offers pre-formulation and formulation development, along with clinical trial material manufacturing and packaging services. WuXi said the merger will offer clients a complete set of manufacturing services for small molecule drugs, speeding up the development process.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES